Lu, Juan <br/><br/>
EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.  [electronic resource] 

 -  Oncotarget  Nov 2014 
 - 11319-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2435  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3' Untranslated Regions<br/>Angiogenesis Inhibitors--genetics<br/>Animals<br/>Base Sequence<br/>Carcinoma<br/>Cell Line, Tumor<br/>Cell Proliferation--physiology<br/>Chick Embryo<br/>Endothelin-1--biosynthesis<br/>Enhancer of Zeste Homolog 2 Protein<br/>Gene Knockdown Techniques<br/>Heterografts<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Mice<br/>MicroRNAs--antagonists & inhibitors<br/>Nasopharyngeal Carcinoma<br/>Nasopharyngeal Neoplasms--blood supply<br/>Neovascularization, Pathologic--metabolism<br/>Polycomb Repressive Complex 2--biosynthesis<br/>Transfection